NTBL: Kapitalisasi pasar Notable Labs Corp

The market valuation chart for Notable Labs, Ltd. (NTBL) demonstrates a capitalization of . The business focuses on creating personalized cancer treatment regimens by selecting optimal medications through the analysis of a patient's live cells. Development relies on a team of visionaries and IT specialists working remotely. Meanwhile, Notable Labs, Ltd. (NTBL) minimizes infrastructure costs by outsourcing routine tests to third-party contractors while retaining key patents.

NTBL notablelabs.com: Nilai pasar ing interval 23.10.2026 - 23.10.2026

Rincian metrik lan analitis perusahaan Notable Labs Corp (NTBL)

Pambiji fundamental perusahaan:Notable Labs NTBL

Market capitalization determines the aggregate value of all an issuer's shares, serving as an indicator of investment confidence. The dynamics of a business's market capitalization demonstrate the balance of supply and demand, which is critical for asset indexing. This metric is calculated as the product of the current share price and the total number of outstanding shares. For Notable Labs, Ltd. (NTBL), this figure reflects the market valuation of the scaling potential of its IT platform for selecting oncology drugs. The increase in value confirms the success of its expansion into the B2B contract segment with biopharmaceuticals.

Pesaing Notable Labs, Ltd. (NTBL)

BeiGene - Biji pasar|Nilai pasar HALO (Halozyme Therapeutics, Inc.)|RevMed - Kapitalisasi pasar|AAPG: Nilai pasar|CG Oncology, Inc. (CGON) - Nilai pasar|URGN (urogen.com) - Nilai pasar|BCAX (Bicara Therapeutics) - Kapitalisasi pasar|Biji pasar Personalis Inc (PSNL)|Kapitalisasi pasar ERAS|Kapitalisasi pasar Delcath Corp (DCTH)|Nilai pasar Y-mAbs Therapeutics YMAB|AURA: Kapitalisasi pasar|Candel - Kapitalisasi pasar|Accuray Inc (ARAY) - Biji pasar|SLS: Kapitalisasi pasar|Nilai pasar Actuate Therapeutics Inc (ACTU)|Nilai pasar Citius Oncology, Inc.|HURA: Nilai pasar|Biji pasar TARA (Protara Therapeutics, Inc.)|FATE (Fate Therapeutics Inc) - Nilai pasar|Kapitalisasi pasar WHWK (Aadi Bioscience)|TCRX - Biji pasar|CSBR: Biji pasar|XBIT - Kapitalisasi pasar|cel-sci.com (CVM) - Nilai pasar|OS Therapies Inc. - Nilai pasar|RADX (Radiopharm Theranostics) - Kapitalisasi pasar|Nilai pasar Artiva ARTV|Nilai pasar Adlai Nortye Ltd. (ANL)|verupharma.com - Kapitalisasi pasar|Nilai pasar Tempest Therapeutics, Inc. TPST|Xilio Therapeutics Inc (XLO) - Nilai pasar|RENB: Biji pasar|Mural Oncology plc - Nilai pasar|KAPA: Kapitalisasi pasar|OnKure Therapeutics (OKUR) - Kapitalisasi pasar|GDTC (CytoMed Therapeutics Ltd) - Kapitalisasi pasar|Nilai pasar CRIS|Nilai pasar Apollomics, Inc. (APLM)|Nilai pasar THAR (Tharimmune Corporation)|Kapitalisasi pasar ADVB (Advanced Biomed)|genprex.com (GNPX) - Nilai pasar|CLDI: Biji pasar|Nilai pasar SBFM (sunshinebiopharma.com)|xeneticbio.com (XBIO) - Nilai pasar|SLRX (Salarius Pharma) - Nilai pasar|PPBT (Purple Biotech) - Kapitalisasi pasar|Kapitalisasi pasar AON|Kapitalisasi pasar BGNE|Nilai pasar CKPT (Checkpoint Therapeutics Inc.)|Nilai pasar Elevation Oncology ELEV|Kapitalisasi pasar iCAD Inc. (ICAD)|IKNA: Biji pasar|Nilai pasar VIRX (Viracta Therapeutics)|MorphoSys (MOR) - Nilai pasar|NAYA (NAYA Biosciences Inc) - Nilai pasar|Biji pasar AAPGV